D-cycloserine Adjunctive Treatment for Posttraumatic Stress Disorder (PTSD) in Adolescents

Completed · Phase 2 · Has a placebo group

Conditions studied: Posttraumatic Stress Disorder, PTSD

In brief

The purpose of this study is to show whether D-cycloserine in combination with cognitive behavioral therapy (CBT) is more effective than CBT plus placebo to reduce symptoms of posttraumatic stress disorder (PTSD) in 13-18 year-old children.

Key facts

Study ID

NCT01157429

Run by

Tulane University School of Medicine

People needed

24

Starts

2010-06-01

Expected to finish

2012-06-01

Last updated by the study team

2017-06-06

Who can join

Age: 13 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Certain number of PTSD symptoms plus functional impairment
• Must be able to swallow pills

You may not qualify if…

• Serious kidney or liver disease
• Epilepsy
• Bipolar disorder
• Psychosis

Where it is running

• Tulane University Health Sciences Center, 1440 Canal St. — New Orleans, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.